Searched for
ESOMEPRAZOLE
Glenmark gets USFDA nod to market generic drugGlenmark Pharmaceuticals announced that it has received USFDA approval to market its generic Esomeprazole Magnesium delayed-release capsule...- Granules India gets USFDA nod for generic drug used for short-term treatment of heartburnGranules India has received approval from the US Food & Drug Administration (USFDA) for its generic Esomeprazole Magnesium delayed-release ...
- Cipla recalls over 5.8 lakh packets of gastric ulcer treatment drug in USThe drug major is recalling esomeprazole magnesium for delayed-release oral suspension in unit dose packets in strengths 10 mg, 20 mg and 4...
- Cipla Q1 results preview: Profit to tank 30-50%, sharp margins fall likelyNirmal Bang expects the company to report a 45 per cent decline in net profit at Rs 262.80 crore on a 0.8 per cent fall in net sales at Rs ...
- Dr Reddy's recalls 1,752 bottles of heartburn drug in the USThe ongoing Class III recall is on account of "Discolouration" and because the product contains brown pellets, USFDA said. As per the US he...
- Cipla gets USFDA nod for generic acid reflux drugThe company has received final approval for its abbreviated new drug application (ANDA) for Esomeprazole for oral suspension in the strengt...
- Sun Pharma gets partial relief from US court in litigation involving three generic drugsDrug major Sun Pharma is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (Dist...
- Glenmark Pharma gets USFDA nod for acid reflux medicationThe approved products is a generic version of AstraZeneca Pharmaceuticals' Nexium delayed-release capsules.
- Aurobindo Pharma gets USFDA nod for heartburn drugAurobindo Pharma said it "has received final approval from the US Food and Drug Administration (USFDA) to manufacture Esomeprazole Magnesiu...
- Aurobindo Pharma gets USFDA nod for gastro reflux drugThe company said the launch of the product is based on the settlement terms/litigation outcome with AstraZeneca.
- Dr Reddy's relaunches generic acid reflux drug in USThe company has "relaunched its Esomeprazole Magnesium delayed-release capsules in the US market. The relaunch is due to a change in the ca...
- Dr Reddy's countersues AstraZeneca over purple pillDr Reddy's Laboratories, has filed a complaint in a US court alleging that AstraZeneca "knew" about its plans to use the same colour in the...
- Dr Reddy's restrained from selling generic drug Nexium in US marketNexium is used to treat severe gastric diseases. The company said the order has been passed pending further hearing or trial.
- Expect to complete US acquisitions by begnining of next quarter: Subhanu Saxena, Cipla"We are very happy with our strong results this quarter and growth momentum has continued for the first half of the year."
- Dr Reddy's launches Nexium generic in US marketDrug major Dr Reddy's Laboratories (DRL) has launched the generic version of Astrazeneca's Nexium, used to treat acid reflux, in the US mar...
- DRL net up at Rs 273 crore on strong generic sales in USDr Reddy's Laboratories' third quarter net profit rose to Rs 273.2 crore against a net loss of 521.7 crore in the same quarter previous yea...
- Ranbaxy to supply raw materials for anti-ulcer drugRanbaxy Laboratories, India's largest company by sales, is expected to start supplying raw materials for anti-ulcer drug esomeprazole magne...
- Ranbaxy strikes deal on Nexium with AstraZenecaRanbaxy has entered into a series of out-of-court settlements with AstraZeneca with estimates of a revenue upside of $1.25-1.5 billion. Go ...
- Ranbaxy to sell ulcer drug Nexium in USRanbaxy Pharmaceuticals Inc, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has announced that it has reached an agreement with pha...
- Ranbaxy receives USFDA approval for esomeprazole capsulesRanbaxy Laboratories has received tentative approval from the US Food and Drug Administration for esomeprazole magnesium delayed-release ca...
Load More
